SCHEMBL3846964

SCHEMBL3846964

CC(C)(C)c1ccc(O)c(C2C3CC4CC(C3)CC2C4)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 3/20 0.47
GAA P10253 3/20 0.47
KMT2A Q03164 3/20 0.47
PKM P14618 2/20 0.47
RECQL P46063 1/20 0.47
HSD17B10 Q99714 2/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CYP2D6 P10635 4/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SIRT1 Q96EB6 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
LMNA P02545 1/20 0.34
TYR P14679 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL396122 0.78 ALOX15 (0.42) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL16046506 0.78 CHRNB2 (0.38) ALDH1A1MEN1GAAKMT2AHSD17B10
SCHEMBL22321085 0.76 MEN1 (0.41) MEN1GAAKMT2AESR1SCN9A
SCHEMBL8796193 0.75 CXCR3 (0.36) MEN1GAAKMT2ACYP2D6CYP1A2
SCHEMBL4614199 0.73 SCN9A (0.35) MEN1GAAKMT2ASCN9APOLB
SCHEMBL6927713 0.71 ALDH1A1 (0.52) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL11308536 0.71 ALDH1A1 (0.52) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL3133679 0.70 CYP2D6 (0.54) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL26608153 0.70 CYP2A6 (0.37) ALDH1A1MAPTMEN1KMT2ARECQL
SCHEMBL345589 0.70 HTR2A (0.42) ALDH1A1MAPTMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118598909-B Preparation and application of OP bidentate fifth subgroup pentavalent metal complex 天津大学 2025-01-24 CN disclosed
CN-118598909-A Preparation and application of OP bidentate fifth subgroup pentavalent metal complex 天津大学 2024-09-06 CN disclosed
US-20090149555-A1 METHOD FOR PREPARING POLYHYDROXYALKANOATES, POLYMERS THUS OBTAINED, COMPOSITIONS COMPRISING THEM AND THEIR USES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-06-11 US disclosed
US-6326397-B1 OSTEOPOROSIS HOFFMAN-LA ROCHE INC. 2001-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149555-A1 METHOD FOR PREPARING POLYHYDROXYALKANOATES, POLYMERS THUS OBTAINED, COMPOSITIONS COMPRISING THEM AND THEIR USES HACL2, DECR1, MGLL ALDH1A1 3795/4885MAPT 3986/4885MEN1 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.